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Abstract 
Early-career academic cardiologists currently face unprecedented challenges that threaten a 
highly valued career path. A team consisting of early career professionals and senior leadership 
members of American College of Cardiology (ACC) completed this white paper to inform the 
cardiovascular medicine profession regarding the plight of early career cardiologists and to 
suggest possible solutions. This paper includes: (1) definition of categories of early career 
academic cardiologists, (2) general challenges to all categories and specific challenges to each 
category, (3) obstacles as identified by a survey of current early career members of the ACC, (4) 
major reasons for the failure of physician-scientists to receive funding from National Institute of 
Health/National Heart Lung and Blood Institute (NIH/NHLBI) career development grants, (5) 
potential solutions, and (6) a call to action with specific recommendations.  
 
Key words: Early Career Academic Cardiologist, Physician-Scientist, Clinician-Educator, 
Academic Medical Center 
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INTRODUCTION 
The majority of advances in cardiovascular care emerge from academic medical centers 
(AMCs) through research, publication, and development of clinical protocols by physicians and 
scientists(1).Our ability to advance knowledge, to develop novel technologies/therapeutics, to 
educate trainees, and to provide quality care is currently in jeopardy due to increasingly 
challenging conditions placed on AMCs and early-career academic cardiologists. As heart 
disease remains the number one cause of death in the United States (2) and 40% of Americans 
will develop some form of cardiovascular disease by 2030 (3), academic cardiologists in 
conjunction with AMCs strive to continually improve cardiovascular care through discovery and 
teaching. 
Early-career academic cardiologists, defined as those who are within 10 years of 
completion of a cardiology fellowship training program, often find themselves challenged to 
remain in academics and thus must consider a transition to non-academic practice. Many early-
career cardiologists view a career in academics as an opportunity to make discoveries that may 
lead to new therapies or influence clinical practice in substantive ways. Others view it as an 
opportunity to educate and train the next generation of providers. Sadly, current uncertainties 
regarding the viability of an academic career are driving many early-career academic 
cardiologists away. 
In light of these developments, the early-career professional section of the American 
College of Cardiology (ACC), along with senior leadership, initiated this manuscript to 
summarize challenges faced by early-career academic cardiologists, to present data on perceived 
obstacles, and to discuss potential solutions to these challenges and obstacles. 
DEFINING THE ACADEMIC CARDIOLOGIST 
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Physician-Scientist. Physician-scientists provide direct patient care and conduct research as 
principal investigators (PIs). They formulate research hypotheses based on existing data and their 
experience in treating patients. They then test their hypotheses by means of basic, translational, 
or clinical research, culminating sometimes in intellectual property development. 
Responsibilities of these individuals include overseeing research, publishing results, and writing 
grants to obtain external funding. Physician-scientists are often expected to provide didactic 
lectures to medical students and to serve as the teaching attending for medical students and 
residents on hospital services. By participating in both clinical and research domains, physician-
scientists provide a critical bridge to translate clinical observations into the realm of scientific 
discovery and to return new-found knowledge to direct patient care.  
Scientist-Researcher. Scientist-researchers dedicate nearly 100% effort to research. While their 
investigative responsibilities are similar to those of a physician-scientist, scientist-researchers do 
not have clinical duties. 
Clinician-Educator. Clinician-educators dedicate a significant amount of time to educational 
activities: participating in preceptorships, presenting didactic lectures to housestaff and students, 
and participating as instructors in formal coursework offered through an associated medical 
school and/or graduate medical education program. The relative distribution of effort among 
these activities for clinician-educators is predominantly clinical. More recently, preceptor and 
mentor roles have extended beyond the traditional medical trainee to include allied health 
professionals, such as physician assistants, nurse practitioners, and pharmacy students. 
Clinician-Educator-Administrator. Clinician-Educator-Administrators have responsibilities in 
course administration, rotation administration, and clinical operations added to the role of 
clinician-educator. Administrative roles include program director, director of clinical cardiology, 
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or medical school course director. Some may chair or co-chair institutional, regional, national, or 
international continuing medical education courses.  
Pure Clinician. Pure clinicians have the primary role of providing direct patient care. Unlike the 
other types of academic cardiologist, pure clinicians are contracted to dedicate essentially 100% 
of their allotted effort to direct patient care. Pure clinicians who wish to maintain academic 
interests must do so outside of their allotted and expected clinical time, whereas other categories 
of academic cardiologist usually have defined protected time for academic pursuits.  
CHALLENGES  
Common challenges are summarized in Table-1 and specific challenges facing each 
category of early-career academic cardiologists are summarized in Table-2.  
Challenges Felt by Current Academic Leadership of ACC 
Cuts in research support, pending cuts in graduate medical education (GME), and the 
decline in reimbursements for clinical activities have come together to create a “perfect storm” 
that threatens the future health and health care of our nation. These events also threaten early 
career investigators during this particularly vulnerable career phase. Academic medical centers 
are challenged by these cuts as well. Left unchecked, this present course will render our nation 
ill-equipped to meet our rapidly expanding healthcare needs. Further, it is already jeopardizing 
our nation’s longstanding predominance in health care research and innovation.  
A career in biomedical discovery coupled with the practice of clinical medicine requires 
many years of preparation, often involving earning both MD and PhD degrees. As such, it is not 
uncommon for an academic cardiologist to assume a first faculty position in his/her late 30’s. 
New faculty often faces extended “dry spells,” while the numerous skills required for success in 
academia are still in development. Bright, ambitious, well-trained physicians – who seek to 
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discover and advance the field – are sometimes unable to navigate this difficult phase of the 
academic career path. There is a lack of societal awareness and interest in fostering this career 
track, failing to recognize its importance to the future healthcare needs of our world. Future 
benefits to society through enhanced longevity, improved quality of life, economic growth, and 
tax revenues are at risk. 
VIEW FROM THE GROUND 
Survey Design 
The ACC conducted an online survey of its early-career membership between September 
and October, 2013. Email survey invitations and three follow-up reminders were sent to 2,957 
randomly selected individuals within this member group. Inclusion criteria included being within 
10 years of fellowship completion and self-identification as an academic cardiologist. 218 out of 
the 324 responses met the inclusion criteria. The majority (87%) resided in the US, were male 
(71%), and completed training within the last five years (58%). Self-identified distribution of 
categories were as follows: scientist-researcher (1%); physician-scientist (8% at >75% research, 
13% at 40-75% research, and 38% at < 40% research); clinician-educator (25%); and clinician-
educator-administrator (15%). Whereas this survey resulted in a modest response rate, the ACC 
market survey team estimates that 7%-10% of the 8651 early career cardiologists within the 
ACC are academic cardiologists.  
Results 
The majority (85%) of early career academic professionals actively sought an academic 
position (Figure 2). Top reasons included academic environment (81%), desire to teach (70%), 
and interaction/exposure to diverse disciplines and new ideas (70%). Approximately two-thirds 
(64%) indicated a desire to conduct research as a motivation to seek out an academic position. 
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Furthermore, 57% of respondents stated the ability to do greater good as a reason for their 
choice. A smaller fraction of respondents (13%) indicated reduced clinical responsibility as a 
reason. 
The vast majority of respondents (88%) strongly believed that physicians need to lead or 
be part of healthcare research. However, respondents identified multiple obstacles (Figure 3). A 
majority pointed to lack of time (78%), unstable funding (73%), burdensome regulatory 
compliance (72%), the disadvantage of competing against pure PhDs (69%), over-emphasis on 
relative value unit (RVU)-based metrics of performance which can discourage academic pursuits 
(62%), and insufficient support from the home institution (52%).  
The vast majority (91%) reported insufficient external funding (defined as equivalent to 
NIH/NHLBI K08/K23 direct funding of $500,000), which is a major challenge for progression 
into a stable academic career. The distribution of external grant funding resembled a negative 
exponential curve: 80% (no funding), 11% ($5K-499K), 5% ($500K-999K), and 4% (>$1M). 
NIH grants accounted for approximately 43% of external funding for academic pursuits of early-
career academic cardiologists (median: $117,500). Non-NIH grants accounted for a larger 
percentage of the external funding (median: $126,000). 
Correlation analyses revealed the following factors as associated with a greater ability to 
obtain >$500K of external funding (Figure 4): onsite mentoring, sufficient institutional 
resources, collaborative connections, and the perception that one’s institution values academic 
pursuits. 
 
Economic difficulties experienced by the academic cardiologist included financial 
disincentives and RVU tracking (Figure 5). Most practitioners (71%) reported the reduction in 
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pay required to pursue academic endeavors as a significant disincentive. Nearly half of 
respondents (49%) reported a reduction of ≥ $75,000 per year. The majority of academic 
practitioners (79%) reported that RVUs are tracked and nearly half (46%) did not receive RVU-
like credit for academic endeavors. Clearly, this focus on clinical productivity leaves less time 
for two important motivators of the academic professional: research and teaching. 
Survey Conclusions 
Tangible factors such as onsite mentoring, institutional commitment, and the availability 
of collaborators directly contribute to the success of early-career cardiologists. Thus, 
development of these resources where they do not exist, and preservation of them where they do, 
are essential. Interestingly, institutional value placed on academic pursuits also contributes to 
successful grant applications, demonstrating the need for recognition of non-RVU generating 
activities of early career academic cardiologists. 
Our survey lends objective credence to the concern that the career path of academic 
cardiology is in peril and that early-stage faculty are particularly challenged. The NIH/NHLBI 
K-grants funding level of $500K is critical to providing dedicated research time, but does not 
cover research-related costs (e.g., equipment, personnel, reagents, animals, and clinical database 
access). Thus, we believe that the 91% of survey respondents who have not achieved this level of 
funding are challenged to emerge with success in the research arena. Moreover, the lack of 
institutional recognition of academic endeavors (e.g. RVU credit) and pay reductions further 
discourage early career members from continue to pursuit academic cardiology.  
NIH/NHLBI CRITIQUE 
Despite decreases in total funding amount and award success percentage (Figure 6), 
NIH/NHLBI career development K08 (basic research) and K23 (clinical research) grants remain 
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relatively obtainable. In 2012, the funding success rates were 32.1% and 20.9% for K08 and K23 
respectively (4). Between 2007-2010, 49% of K08 grants were awarded to adult cardiology(5). 
Thus, NIH/NHLBI career development grants remain viable sources of grant support for early-
career academic cardiologists. However, all K-grants are grouped together and awarded by their 
priority score without regard to sub-categories (i.e., K01, K02, K08, K12, K23, K24, K25, 
K99/R00); consequently, early-career academic cardiologists compete with more established 
applicants (e.g. mid-career K02). In this light, we have worked with NHLBI program officers 
and a past chairman of K-grants review study section to compile a list of major reasons for the 
failure of physician-scientists to receive funding (see Table 3).  
Successful K-grants provide robustly positive impact on the development of early career 
cardiologists. These grants require institutions to allocate 75% dedicated research effort. This 
dedicated research time provides the early-career professional with time to develop critical skills 
and to acquire preliminary observations and reagents. In other words, these career development 
awards are a pivotal juncture in the emergence of a cardiologist-scientist. 
POTENTIAL SOLUTIONS 
Improving Fellowship Training 
We must better prepare fellows to succeed early in their careers. However, changes in 
fellowship training needed to meet this goal must occur without extending the current fellowship 
duration of 3-5 years. 
Allocating dedicated research time during fellowship training correlates with the decision 
of fellows to pursue an academic career (6-10) and allows for the completion of research 
resulting in publication during fellowship (6-10). The NIH/NHLBI’s top reasons for failure to 
obtain grants (Table-3) emphasize the need for fellows to be better prepared. This preparation 
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includes proposal writing, proficiency in specialized research skills (e.g., basic, clinical, and 
translational research techniques), and completion of transferable products (e.g. novel reagents). 
Inherent in the ability to train competitive fellows is dedicated research time. 
Mentorship is a critical part of all training programs (7, 8, 10, 11), and outstanding 
mentors should be acknowledged and rewarded by institutional leadership. The NIH/NHLBI 
critique illustrates that the quality of mentorship needs to improve. Protected time for the mentor 
and credit for successful mentoring will help create a strong group of future mentors. 
Opportunities for education on the broader range of skills pertinent to the academic 
practice should be expanded. Fellows must be adept at delivering cost-effective care with 
attention to error prevention(12). Furthermore, department chairs, program directors, and other 
clinical leaders should educate fellows on the details of their specific supervisory functions (e.g. 
department, lab). As time constraints of fellowship training will not allow education of all 
fellows in all of these areas, programs must provide flexibility in aspects of their training 
program to allow for acquisition of specific skills needed for given career paths. 
Fellows choosing a clinician-educator track need formal training in education to navigate 
the complexities of curriculum development, educational assessment, and accreditation 
regulations. Training in educational methodology and mentorship are critical for those striving 
for excellence as an educator. Training in educational research will help clinician educators 
produce scholarly work related to their teaching effort and contribute to their understanding of 
best practices in medical education. 
Developing Novel Partnerships and Alternative Funding Sources 
Partnership between university systems and clinical entities can provide stability during 
early career years. Under this type of partnership, a university system supports a portion of salary 
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dedicated to academic pursuits while the clinical entity provides support for effort dedicated to 
patient care. Any salary support for the academic cardiologist derived from external grants is 
counted as salary savings to the university system and then re-applied toward the academic 
cardiologist’s research. This partnership provides stability and amplifies the effect of external 
grants. This type of partnership, successfully implemented at Texas A&M University partnering 
with Baylor Scott & White Healthcare, provides upfront stability for roughly five years.  
Creating partnerships with institutions hosting a Clinical and Translational Science 
Award (CTSA) from the NIH can be helpful. A portion of CTSA funds is used to support the 
training of early stage investigators, including KL2 Career Development Awards. Similar to 
NIH-K awards, these awards mandate 75% protected time for research and related career 
development activities and typically provide approximately $25,000/year in research support. 
These awards often include a didactic component and provide for coursework towards a master’s 
degree in clinical investigation.  
Another alternative source for funding are investigator initiated trials (IIT), through 
which uses for newer drugs or new uses for established agents (13) are investigated. Establishing 
training and research partnerships with pharmaceutical companies outside of IITs is also 
possible. For example, Rutgers Pharmaceutical Industry Fellowship Program involves 
participation of 17 pharmaceutical companies to fund 1-2 years of training in research and 
advocacy for those who hold doctorates in pharmacology(14). However, pharmaceutical 
partnerships require special focus to ensure that conflicts of interest, or the appearance thereof, 
do not emerge.  
Access to key personnel, information regarding funding opportunities, and knowledge of 
resources are crucial to obtaining external grants. Thus, creation of regional network of 
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collaborators, mentors, and networks of sharable resources can enhance access to early-career 
professionals. Electronic media allows for remote mentoring. Regional sharing of resources 
allows for experiments to occur when the home institution lacks the capability of conducting 
experiments locally. The ACC is well positioned to facilitate these efforts.  
The Early Career Professional section of the ACC has initiated a College-wide 
mentorship program. Additionally, a new partnership between the ACC and infoEd 
(https://acc.spin.infoedglobal.com/Home/GridResults) has established a searchable database of 
funding resources, providing members access to information that would otherwise be difficult to 
locate.  
Seeking Policy Changes 
We must better educate the public, elected representatives, and regulatory officials 
regarding the critical importance of medical education and research(15). The reduction in deaths 
due to coronary artery disease from ~470/100,000 per year in the1960s to ~150/100,000 per year 
in 2010 (1) is an excellent example of the benefit achieved by cardiovascular innovation. Despite 
this, cardiovascular disease remains the leading cause of death in the US (2) and heart failure is a 
progressive disease with 5-year mortality greater than most cancers(16-18). Clearly, more 
research is needed. Increased awareness is critical in enhancing societal investment in research to 
tackle the grave issues. 
A major reason for declining societal investment in medical education (GME) has been 
our failure to demonstrate the value that AMCs provide to society. We must reinforce to the 
public that AMCs perform critical functions: training the next generation of physicians, hosting 
the majority of medical advances, treating the most vulnerable and challenging populations (e.g. 
those who require multi-disciplinary care, those with advanced diseases not treatable elsewhere, 
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and those who are indigent). Furthermore, increased GME funding is critical to ensure that 
AMCs are prepared for the increases in patients accessing our healthcare system as a result of the 
Affordable Care Act.  
Advocacy requires direct involvement. Our role as academic cardiologists must be 
explained and justified to the public. We must do a better job of determining the return on 
societal investment and communicating that information. This public education needs to begin at 
the regional and state level. Ultimately though, to best effect policy change, these efforts must be 
coordinated at the national level.  
The cost for caring of cardiovascular disease patients has risen significantly (19, 20). We 
must contain this growth in costs and demonstrate to the public that we are consciously working 
to trim expenditures. Finding efficient ways to treat patients and reduce expenditures can bend 
the cost growth curve. Actual savings may translate into broader overall support for development 
of physician-investigators dedicated to enhancing our future.  
CALL TO ACTION 
We are witnessing a convergence of events that threaten the existence of the academic 
cardiologist career path. Traditional mechanisms of research support and investment in education 
are declining. Competition for funding continues to increase. In response, some institutions are 
devaluing the academic enterprise. Our survey and NIH/NLHBI critique suggest strongly that 
early-career academic cardiologists are facing career-threatening challenges, arguably more so 
than ever. Failure to renew the pipeline of academic cardiologists threatens our ability to meet 
the healthcare needs of the future. Thus, we call on the ACC and our colleague-members to act 
on the following specifics (Table-4) for the good of society and the preservation of our 
profession.  
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FIGURE LEGENDS 
 
Figure 1: NIH/NHLBI Funding and Proposal Success Rate by Year  
(A) NHLBI funding grew rapidly from 2000 to 2005, grew again by smaller increments from 
2008 to 2010, and declined steadily since 2010. (B) NHLBI proposal success rates have declined 
from 29.2% in 2003 to 13.3% in 2012. Data were extracted from references (21, 22). 
 
Figure 2: Reasons for Choosing Academic Cardiology 
A majority of the early academic cardiologists actively sought academic positions for altruistic 
reasons. 
 
Figure 3: Perceived Obstacles to Academic Pursuits 
Survey identified complying with regulatory burden, unstable funding, detrimental use of RVUs, 
being disadvantaged when competing with PhDs, lack of good onsite mentoring, home 
institution lacking resources, lacking collaborators, lacking bridge funding, and insufficient time 
during work hours as major obstacles. 
 
 
Figure 4: Factors Leading to Obtaining >$500K of External Grants (red arrows) 
Spearman’s Rho analyses identified factors that correlated with success in obtaining >$500K of 
external grant funding. These factors include home institution placing value on academic 
pursuits, excellent onsite mentoring, home institution possessing sufficient resources, and readily 
available collaborators.  
 
Figure 5: Financial Disincentives for Early-Career Academic Cardiologists 
(A) Early career members generally did not receive RVU credits for academic pursuits, and (B) 
took reductions in pay for pursuing academic cardiology.   
 
Figure 6: NIH/NHLBI Funding of Career Development Grants by Year   
NHLBI funding of K08 (basic research) and K23 (clinical research) career development grants 
fluctuated from 2003-2012 in proposal success rate (A) and amount (B). Data were extracted 
from reference (4).   
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Table 1: Common Challenges 
Traditional sources of funding have declined 
Federal National Institutes of Health/National Heart and Lung and Blood Institute 
(NIH/NHLBI) 
 Funds vast majority of cardiovascular research 
 Budget plateaued in 2010 and then declined (Figure 1)(22, 23) 
 Grant funding success rates have steadily decreased by >50% from 2003 to 2012 
(Figure 1)(22, 23)  
 Using 1995-constant US dollars, NIH 2013 budget was 22% lower than 
2003(24) 
General Medical Education (GME) 
 Medicare support of GME has been frozen at 1996 levels(25) 
 Frozen cap led to 12% decrease in cardiology fellowship slots in 1995-2001(11) 
 Presidential budgets proposed to reduce indirect Medicare support of GME by 
10%(25-27) 
Industry  Research spending for new cardiovascular therapies has been declining (28, 29) 
 Cardiovascular drug development has decreased(30) 
Increasing number of PhDs competing for smaller available funding pool  
 Life-science/medical PhDs awarded per year grew from <2000 in 1993 to >8000 in 2007(31) 
 Biological sciences PhDs awarded per year grew from <5000 in 1993 to 8052 in 2010(31, 
32) 
 PhD growth likely contributed to steadily increasing number of grant applications (Figure 1) 
Over-reliance on relative value units (RVU) discourages academic pursuits 
 Medicare pays by [current procedure terminology code (CPT)) X (RVU) X (conversion 
factor)) 
 Medicare formula does not reimburse academic pursuits 
 Consequently, healthcare systems do not award RVU “credit” to academic pursuits 
 Academicians are forced to add RVU tasks in lieu of academic pursuits 
Trends in medicine and academia reduce available time for investigator-initiated academic 
pursuits 
 Progressive limitations on house-staff increasingly shift work to cardiology faculty 
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 Explosive growth of complex regulatory compliance requirements add increasing 
administrative burdens (e.g., Institutional Review Boards, Institutional Biological Safety 
Committee, Institutional Animal Use and Care Committee, and Environmental Health 
Safety)    
 More time is required to maintain expert competency 
 Increasing number of studies and guidelines for each subspecialty 
 Increasing requirement for formal demonstration of competency (e.g. yearly maintenance 
of certification exercises and more frequent board certification exams) 
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Table 2: Category Specific Challenges 
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 Difficulties in acquiring, maintaining, and demonstrating skills 
 Fall behind in research skills and miss new technologies due to years spent in 
residency and clinical portions of fellowship 
 Clinical skills deteriorate due to time spent in research 
 Less time to acquire research skills and  
 Less time to demonstrate potential (2-3 years) vs. (5-7 years) for pure PhDs 
 Disadvantages when competing for grants 
 NIH K99/R00 and American Heart Association fellow-to-faculty transition grants 
require additional year(s) after completion of clinical portion of training 
 Extra year(s) can lead to deterioration of clinical skills just before becoming an 
attending physician responsible for an in-patient service 
 Extra year(s) may not be financially viable for fellows 
 As evidenced by 88% of K99/R00 grants being awarded to pure PhDs(5), NIH 
program officers view this granting mechanism as ill-suited for the clinicians 
 Compete against established PhDs for career development grants 
 NIH K08 (basic science) and K23 (clinical science) meant to help early-career 
physician-scientists 
 NIH K02 meant to support established mid-career PhDs with existing grants 
 Review process combines and ranks all K-grants together , awarding 
applications with scores above pay line 
 Efforts spent in clinical endeavors reduce publication quantity and time available 
for developing grants   
 Funding shortfalls even after obtaining competitive grants 
 Career development awards require 75% dedication to research but do not cover 
75% of typical physician’s salary 
 Remaining clinical effort cannot cover salary gap 
 Remaining clinical effort may not provide sufficient time to acquire procedure 
numbers to formally demonstrate competency needed for higher paying clinical 
skills (e.g. 75 percutaneous coronary intervention per year(33)  
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 Difficulties in meeting new formal education requirements for excellence (e.g. adult 
education principles, outcomes assessment, curriculum development) 
 Lack onsite mentoring and training 
 Lack access to professional educational programs such as Harvard Macy 
 Clinically based performance measures decrease ability to teach residents and fellows 
 Expected to provide novel educational content 
 Lectures, divisional teaching conferences, grand rounds, continued medical 
education 
 Website development 
 Educational efforts are rarely reimbursed 
 Teaching focus does not lead to attainment of traditional measure of academic 
productivity such as publications and grants  
 Clinician-Educator-Administrator face additional challenges 
 Ensure the home organization is meeting various accreditation requirements (e.g. 
Accreditation Council for Graduate Medical Educations (ACGME), the Joint 
Commission…) 
 Continuously spend effort on understanding and implementing new and often 
complex compliance requirements 
 Compliance measures are now tracked via the internet 
 Must correct deficiencies expeditiously   
 Achieve overall group productivity to stay “in the black” 
 Held accountable for variances 
 Must address low RVU production in real time 
 Administrative work is rarely reimbursed 
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 Majority completing cardiology training fall under this category(34) 
 Healthcare systems demands more clinical time while reducing research support to 
generate revenues(35) 
 Faces paradox of academic pursuit expectation but without needed support 
 Institutions still expect self-driven pursue of academic endeavors (e.g. teaching, 
educational presentations, and research) 
 Lack of protected research time affords major challenges to publication and grants 
 Academic promotion is still based on successful attainment of academic pursuits   
 Academic pursuits go unrecognized in monetary form 
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Table 3: Top Reasons from NIH Official for K-Grant Failure 
 
Applicant appears to be inadequately prepared nor committed to research. The applicant 
did not demonstrate sufficient skill in the area of proposed research as seen by lack of prior first 
author publication and lack of valid preliminary data in the proposal. The applicant did not 
demonstrate commitment to research by lack of prior dedicated research time. Furthermore, the 
applicant seems to suddenly jump into the proposed research without indication of prior 
experience, preparation, or believable motivation. 
 
Career development plan appears to be poorly designed.  Being career development grant, 
reviewers expect to see career development plan that integrates well with research plan. Often, 
applicants fail to demonstrate how the proposed research can directly contribute to their career 
development. 
 
Research proposal is poorly developed. Being early career, applicants have the tendency to 
propose projects that cannot plausibly be completed. Furthermore, research plans lack focus; 
therefore, reviewers doubt that meaningful results can be accomplished for both advancement of 
science and career development.  
 
Mentor does not appear to have the ability to help the mentee. Mentor not having NIH R01 
level type of funding raises doubts about his/her ability to financially help the mentee if the 
research encounters difficulties or needing new methods. Mentor’s letter may not match 
applicant’s career development plans; consequently, reviewers interpret this mismatch as mentor 
being unwilling or unable to commit the necessary effort to help the mentee. Sometimes, the 
mentor does not demonstrate having expertise in the area of proposed research; thus, mentor 
will not be able to help. Since mentoring is an extraordinary crucial part of career development, 
perception of an inadequate mentor will doom the proposal even all other sections are excellent.    
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Table 4: Call to Action Specifics 
ACC Leadership:  
• Create 3-year research grant awards that are dedicated to early-career academic cardiologists 
• Create funding foundation dedicated to support research awards 
• Work with other professional cardiovascular associations to increase the portion of their 
grants to early-career cardiologists  
• Further expand the emerging faculty and leadership programs to foster excellence in teaching 
but also leadership for clinical efforts in academia 
• Create 2-year grants to support cardiology fellows for dedicated research during fellowship 
• Accelerate development and increase funding of key resources for early-career members 
such as the College-wide mentoring program, funding and grants database, and grant writing 
workshops  
• Work with the Board of Governors to develop regional collaboration networks where early-
career cardiologists can learn and access new technology in support of their research 
• Conduct longitudinal studies and surveys with yearly reports on the state of early-career 
academic cardiologists, including all categories defined in this manuscript 
• Work with other medical associations to quantify and reward academic pursuits 
ACC Advocacy: 
• Increase awareness on the continuing severe burden of cardiovascular disease on society 
• Increase awareness of cardiology influences in health care and the dramatic improvements in 
disease treatment fueled by research careers 
• Advocate for increasing NIH funding of cardiovascular research, increasing GME support, 
and dedicating a portion of research funds for physician-scientists 
Division Chiefs and Academic Leadership: 
• Create start-up packages that include protected time and 3-year research support dedicated 
for early-career academic cardiologists 
•  Find methods to measure and reward academic pursuits and teaching 
        Nurture and protect early-career faculty 
• Work with program directors to create innovative teaching for trainees and early-career 
faculty 
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Program Directors: 
• Work with division and departmental leadership to create positions that provide protected 
time for academic pursuits including research, teaching, and training for academic 
cardiologists 
• Work with division and departmental leadership to create and support innovate teaching to 
allow the growth of trainees and early-career members. This would include leadership 
development, funding development, grant writing, clinical operations, and the business of 
medicine (logistics of billing and seeing patients efficiently). 
Established Investigators: 
• Make it a priority to mentor early-career academic cardiologists 
• Incorporate cardiology fellows into your research program 
• Share resources such as laboratory equipment, animal models, databases, techniques, and 
technical support directly and through regional collaboration networks being developed by 
the ACC  
Trainees: 
       Ask your program director(s) for dedicated time to pursue research electives 
• Seek out high quality mentor(s) who have made a priority of helping trainees  
• Follow a clinical leader, and ask for formal didactics on the business of patient care, clinical 
leadership, and research funding 
All Cardiologists:  
       Volunteer to be a mentor. Whether you are in private practice or academics, more mentors 
are needed. 
• Participate as a preceptor, lecturer, or skills teacher in training programs 
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